UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

Acta neuropathologica, 2016-06, Vol.131 (6), p.821-831

2016

Link zum Volltext

Verfügbarkeit prüfen

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

Clinical cancer research, 2020-01, Vol.26 (1), p.242-255

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

Clinical cancer research, 2009-01, Vol.15 (2), p.441-451

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract IA16: Accelerating innovation for children with cancer in the new regulatory environment

Cancer research (Chicago, Ill.), 2020-07, Vol.80 (14_Supplement), p.IA16-IA16

Vassal, Gilles

2020

Link zum Volltext

Verfügbarkeit prüfen

GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma

BMC cancer, 2019-10, Vol.19 (1), p.1018-1018, Article 1018

2019

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models

PloS one, 2015-11, Vol.10 (11), p.e0142612-e0142612

2015

Link zum Volltext

Verfügbarkeit prüfen

New drugs for children and adolescents with cancer: the need for novel development pathways

The lancet oncology, 2013-03, Vol.14 (3), p.e117-e124

2013

Link zum Volltext

Verfügbarkeit prüfen

New policies to address the global burden of childhood cancers

The lancet oncology, 2013-03, Vol.14 (3), p.e125-e135

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review

BMC cancer, 2018-11, Vol.18 (1), p.1159-6, Article 1159

2018

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and Adults

Clinical cancer research, 2008-11, Vol.14 (21), p.7102-7109

2008

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

BMC cancer, 2022-06, Vol.22 (1), p.625-11, Article 625

2022

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma

PloS one, 2012-08, Vol.7 (8), p.e43665-e43665

2012

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models

Frontiers in oncology, 2023-06, Vol.13, p.1166063-1166063

2023

Link zum Volltext

Verfügbarkeit prüfen

Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors

International journal of oncology, 2017-01, Vol.50 (1), p.203-211

2017

Link zum Volltext

Verfügbarkeit prüfen

Changing incentives to ACCELERATE drug development for paediatric cancer

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8825-8837

2023

Link zum Volltext

Verfügbarkeit prüfen

The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program

Targeted oncology, 2021-05, Vol.16 (3), p.381-388

2021

Link zum Volltext

Verfügbarkeit prüfen

Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols

Therapeutic innovation & regulatory science, 2019-03, Vol.53 (2), p.270-278

2019

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma

Molecular cancer therapeutics, 2010-05, Vol.9 (5), p.1219-1233

2010

Link zum Volltext

Verfügbarkeit prüfen

Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients

Pharmaceuticals (Basel, Switzerland), 2022-04, Vol.15 (5), p.555

2022

Link zum Volltext

Verfügbarkeit prüfen

Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis

Cancers, 2020-11, Vol.12 (11), p.3246

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

Clinical cancer research, 2006-10, Vol.12 (20), p.6073-6078

2006

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of phase‐I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research

Cancer medicine (Malden, MA), 2021-03, Vol.10 (5), p.1589-1604

2021

Link zum Volltext

Verfügbarkeit prüfen

How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?

JCO global oncology, 2022-12, Vol.8 (8), p.e2200156-e2200156

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 384

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(369)
Mit Volltextzugriff
(358)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial

Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas

Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

Abstract IA16: Accelerating innovation for children with cancer in the new regulatory environment

GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models

New drugs for children and adolescents with cancer: the need for novel development pathways

New policies to address the global burden of childhood cancers

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review

Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and Adults

Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma

Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models

Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors

Changing incentives to ACCELERATE drug development for paediatric cancer

The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program

Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols

Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma

Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients

Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis

Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

Systematic review of phase‐I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research

How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?

Suchergebnisse filtern